期刊文献+

胰腺癌动物模型的研究进展 被引量:3

Progress in models of pancreatic cancer
原文传递
导出
摘要 胰腺癌是一种高度恶性的肿瘤,通过建直胰腺癌动物模型,可以更加深入地对该疾病进行研究。胰腺癌的动物模型主要包括:移植瘤模型、致癌物诱导模型、基因工程模型。移植瘤模型相对可靠,易于建立,但肿瘤在免疫缺陷动物体内的生长方式与人体内不尽相同;致癌物诱导模型可通过改变环境因素来模拟胰腺癌发生发展的全过程,但其特异性较差;基因工程模型可从分子水平模拟胰腺的发生,但技术要求高,转基因产物难以精确控制。目前尚没有一种胰腺癌动物模型可以满足所有研究的需要,需要根据不同的实验目的选择相应适合的动物模型。 Pancreatic cancer is a highly malignant tumor. Animal models of pancreatic cancer included xenograft models, carcinogen induced models, genetically engineered models. Xenograft models are relatively reliable and feasible, but the growth pattern is different between serve immunodeficienct animals and human beings. Carcinogens induced models simulated the environmental factors to reconstruct the development of pancreatic eancer. But carcinogens could have other biologieal effects. Genetically engineered models could make the occurrenee of pancreatic cancer at the molecular level. But it is difficult to control the transgenic product accurately. No model could meet all the needs of different experiments. It is important to choose a suitable animal model in different experiments.
出处 《国际外科学杂志》 2011年第3期173-176,共4页 International Journal of Surgery
基金 上海市科委基金项目(No.09140902300 No.09YZ84):国家自然科学基金项目(No.30772105:No.30801107)
关键词 胰腺癌 动物模型 异种移植 化学诱导 基因工程 Pancreatic cancer Animal models Xenografl Carcinogen induced Genetically engineered
  • 相关文献

参考文献24

  • 1Jemal A,Siegel R,Ward E,et al.Cancer Statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 2Strimpakos A,Saif MW,Syrigos KN.Pancreatic cancer:from molecular pathogenesis to targeted therapy[J].Cancer Metastasis Rev,2008,27(3):495-522.
  • 3Menon R,Zhang Q,Zhang Y,et al.Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer[J].Cancer Res,2009,69 (1):300-309.
  • 4Rubio-Viqueira B,Jimeno A,Cusatis G,et al.An in vivo platform for translational drug development in pancreatic cancer[J].Clin Cancer Res,2006,12(15):4652-4661.
  • 5Lynch TJ,Bell DW,Sordella R,et al.Activating mutations in the epidermal growth factor receptor underlying responsiveness of nonsmall-cell lung cancer to gefitinib[J].N Engl J Med,2004,350(21):2129-2139.
  • 6Jimeno A,Feldmann G,Suarez-Gauthier A,et al.A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development[J].Mol Cancer Ther,2009,8 (2):310-314.
  • 7Loukopoulos P,Kanetaka K,Takamura M,et al.Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity[J].Pancreas,2004,29(3):193-203.
  • 8Dineen SP,Sullivan LA,Beck AW,et al.The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer[J].BMC Cancer,2008,8:352.
  • 9Uchida E,Matsushita A,Yanagi K,et al.Experimental pancreatic cancer model using PGHAM-1 cells:characteristics and experimental therapeutic trials[J].J Nippon Med Sch,2008,75 (6):325-331.
  • 10Nuhn P,Künzli BM,Hennig R,et al.Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo[J].Mol Cancer,2009,8:37.

同被引文献68

  • 1刘情,郑琳,张灏.人源性肿瘤组织异种移植模型的研究进展[J].转化医学杂志,2014,3(2):65-68. 被引量:6
  • 2Siolas D, Hannon GJ. Patient-derived tumor xenografts: transfor- ming clinical samples into mouse models[ J]. Cancer Res, 2013, 73(17) : 5315-5319.
  • 3Tentler JJ, Tan AC, Weekes CD, et al. Patient-derived tumour xenografts as models for oncology drug development [ J]. Nat Rev Clin Oncol, 2012, 9(6) : 338-350.
  • 4Ellis LM, Fidler IJ. Finding the tumor copycat. Therapy fails, pa- tientsdont[J]. Nat Med, 2010, 16(9): 974-975.
  • 5Menon R, Zhang Q, Zhang Y, et al. Identification of novel alter- native splice isoforms of circulating proteins in a mouse model of human pancreatic cancer [ J ]. Cancer Res, 2009, 69 ( 1 ) : 300- 309.
  • 6Deeamlin D. Primary humar tumor xenografted models ( ' tumor- grafts') for good management of patients with cancer[J]. Anti- cancer Drugs, 2011, 22(9) : 827-841.
  • 7Daniel VC, Marchionni L, Hierman JS, et al. A primary xenografl model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro[J]. Cancer Res, 2009, 69 (g) : 3364-3373.
  • 8Sausville EA, Burger AM. Contributions uf human tumur xenugrafts to anticancer drug development [ J ]. Cancer Res, 2006, 66 (7) : 3351-3354.
  • 9Cree IA, Glaysher S, Harvey AL. Efficacy of anti-cancer agents in cell lines versus human primary tumour tissue[ J ]. Curr Opin Phar- maeol, 2010, 10(4) : 375-379.
  • 10DeRuse YS, Wang G, Lin YC, et al. Tu'nor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes[ Jl. Nat Med, 2011 , 17 (11): 1514-1520.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部